
    
      Investigating the efficacy of Cetuximab Monotherapy versus Continuation after induction
      treatment with chemotherapy + Cetuximab in inoperable or irresectable and non-progressive
      metastatic colorectal cancer after first line induction treatment for 24 weeks with
      mFOLFOX6/FOLFIRI and Cetuximab treatment. Reinduction treatment will be done in case of
      progression. This treatment is continued until progression or severe toxicity.
    
  